A rationally designed oligopeptide shows significant conformational changes upon binding to sulphate ions.
Oligopeptides that interact with oxoanions were developed by rational design methods.
Oligopeptides that interact with oxoanions were developed by rational design methods.
A monoclonal antibody, AC7, directed against the RGD-binding site of the GPIIIa subunit of the platelet fibrinogen receptor, interacts with activated platelet.
Starting from the X-ray structure of a class I major histocompatibility complex (MHC)-encoded protein (HLA-B*2705), a naturally presented self-nonapeptide and two synthetic …